Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology Lead Investing
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update Lead Investing
Pan American Silver Reports Mineral Reserves and Mineral Resources as at June 30, 2025 Precious Metals Investing
Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit Lead Investing
Pan American Silver Reports Discovery of Multiple High-Grade Silver Zones at the La Colorada Mine Precious Metals Investing
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September Lead Investing
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 - September 03, 2025 Lead Investing
